Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04018586 · ClinicalTrials.gov registry record · NA

AVACEN Hand Heating on Fasting Blood Glucose

A NA study of Hypertension and Hyperglycemia, sponsored by Jeff Moore.

Completed
Registry status
NA
Development phase
17
Enrollment target
1
Study location

NCT04018586 is a NA study of Hypertension and Hyperglycemia that has completed, run by Jeff Moore. The registered enrollment target is 17 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04018586, a NA study of Hypertension and Hyperglycemia, has completed, sponsored by Jeff Moore.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

A double-blind crossover randomized controlled trial to investigate the effects of the AVACEN device on fasting blood glucose. The AVACEN device creates negative pressure around the hand while heating the palm. Two sham devices, one providing heat but no vacuum and one providing neither heat nor vacuum were also used. Each subject was tested while using each of these three devices on separate visits. Subjects arrived in the morning following an overnight fast. Fasting blood glucose, blood pressure, tympanic temperature, and subjective thermal ratings were measured before and throughout the 30 minutes that the device was used.

Interventions

  • DEVICE AVACEN 100
  • DEVICE AVACEN 100 Heat Only
  • DEVICE AVACEN Sham

Study Locations (1)

California

  • San Diego State University - San Diego

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2019-02-28
Est. Completion 2019-09-15
Phase NA

Sponsor

Jeff Moore

1 total trials

What the Registry Record Tells You About NCT04018586

The ClinicalTrials.gov registry entry for NCT04018586 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (100% lower). The listed sponsor is Jeff Moore, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 3 interventions - of which AVACEN 100 is the first listed.

NCT04018586 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04018586 about?

NCT04018586 is a clinical study titled "AVACEN Hand Heating on Fasting Blood Glucose". A double-blind crossover randomized controlled trial to investigate the effects of the AVACEN device on fasting blood glucose. The AVACEN device creates negative pressure around the hand while heating the palm. Two sham devices, one providing heat but no vacuum and one providing neither heat nor vac...

What is the current status of trial NCT04018586?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2019-02-28. Estimated completion is 2019-09-15.

What conditions does trial NCT04018586 study?

This clinical trial studies the following conditions: Hypertension, Hyperglycemia.

What interventions are being tested in trial NCT04018586?

The interventions under investigation include: AVACEN 100 (DEVICE), AVACEN 100 Heat Only (DEVICE), AVACEN Sham (DEVICE).

Who is sponsoring clinical trial NCT04018586?

This trial is sponsored by Jeff Moore, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04018586 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.